EcolabvsMediWound

ECL and MDWD stock compared: price, dividend, valuation and results, from SEC filings.

ECL

Ecolab Inc.

$294.70

Value $83.1B

-0.88%
ECL's page

Ecolab (ECL) has a market value of $83.1B and MediWound (MDWD) $174M. Over the last year, with dividends, ECL moved +13.9% and MDWD -23.9%. Dividend yield: ECL 0.99%, MDWD none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ECL$83.1B

    MDWD$174M

    ECL is 476 times MDWD

  • Revenue, 12 months

    ECL$17.4B

    MDWD$17M

    ECL is 1,024 times MDWD

  • Net income, 12 months

    ECL$2.1B

    MDWD-$24M

  • Operating margin

    ECL16.7%

    MDWD-149.0%

    165.7 points apart

  • ROIC

    ECL11.6%

    MDWD-45.8%

    57.3 points apart

  • P/E

    ECL39.9

    MDWD–

  • Dividend yield

    ECL1.0%

    MDWD0.0%

    1.0 points apart

  • 5-year return

    ECL+32.7%

    MDWD-32.4%

    65.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ECL+32.7%

MDWD-32.4%

5010020222023202420252026
Returns by period
PeriodECLWith dividendsMDWDWith dividends
1 year since November 19, 2025+13.9%Price +12.7%-23.9%Price -23.9%
3 years since November 20, 2023+64.3%+18.0% a yearPrice +59.3%+58.8%+16.7% a yearPrice +58.8%
5 years since November 19, 2021+32.7%+5.8% a yearPrice +25.5%-32.4%-7.5% a yearPrice -32.4%
10 years since November 22, 2016+182.2%+10.9% a yearPrice +153.3%-63.4%-9.6% a yearPrice -63.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ECLEcolabMDWDMediWound

Valuation

ECLMDWD
Valuation
Price$294.70$13.59
Market value$83.1B$174M
Enterprise value (EV)$95.6B–
P/E39.9–
P/E, 5-year median38.2–
P/B8.04.0
EV/EBIT32.9–
Free cash flow yield2.2%–

Results and growth

ECLMDWD
Results and growth
Revenue, 12 months$17.4B$17M
Net income, 12 months$2.1B-$24M
Free cash flow, 12 months$1.8B-$22M
Earnings per share, 12 months$7.35-$2.10
Revenue growth, year on year2.2%-16.1%
Revenue growth a year, past+6.4%over 5 years-4.9%over 5 years
EPS growth a year, past––

Margins and returns on capital

ECLMDWD
Margins and returns on capital
Gross margin43.9%19.2%
Operating margin16.7%-149.0%
Net margin12.0%-140.8%
ROIC11.6%-45.8%
ROE20.8%-54.7%

Balance sheet

ECLMDWD
Balance sheet
Cash$722M$4.8M
Total debt$13.4B–
Net debt / EBITDA3.5–
Interest cover7.4×-10.3×

Dividends and buybacks

ECLMDWD
Dividends and buybacks
Dividend yield1.0%–
Dividend per share, 12 months$2.92–
Dividend growth a year, past+7.2%over 5 years–
Buyback yield0.9%–
Shareholder yield1.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ECL or MDWD

Didn't find what you were looking for?

Ask us
Which is bigger, Ecolab or MediWound?

By market value, Ecolab ($83.1B) is about 476.4 times MediWound ($174M), at today's prices.

How did ECL and MDWD stock do over the last 10 years?

Since November 22, 2016, ECL's price moved +153.3% and MDWD's -63.4%. With dividends: ECL +182.2% (+10.9% a year), MDWD -63.4% (-9.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ECL or MDWD?

The dividend yield at today's price is 0.99% for Ecolab and none for MediWound. Over the last twelve months they paid $2.92 and – per share.

Which has the higher profit margins, Ecolab or MediWound?

Over the last twelve months, the net margin was 12.0% for Ecolab and -140.8% for MediWound, and the operating margin 16.7% and -149.0%. Revenue was $17.4B and $17M.

Which is the better investment, Ecolab or MediWound?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.